Yesterday’s limitations are tomorrow’s opportunities. Contribute to knowledge bases, find signatures, and research elusive new cancer mutations with whole exome sequencing tools by IDT. With the most complete coverage, established quality metrics, and a broad range of customizable solutions, IDT’s whole exome sequencing (WES) solutions offer greater confidence for cancer researchers.

In this multi-session virtual event, attendees will:

Learn about the past, present, and future applications of whole exome sequencing.
Explore how whole exome sequencing (WES) is advancing new discoveries in oncology, rare disease, and pharmacogenomics research.
Discover how labs are successfully incorporating AI technologies within their exome analysis workflows.
Hear how researchers are partnering together to create a data-driven ecosystem with whole exome sequencing technology.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.